MeSH term
Frequency | Condition_Probility | Aged | 8 | 0.0 |
Humans | 78 | 0.0 |
Time Factors | 5 | 0.0 |
Leukocytes/immunology | 3 | 2.0 |
Receptors, CCR5/analysis | 2 | 4.0 |
Research Support, Non-U.S. Gov't | 58 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Acute Disease | 2 | 0.0 |
Gene Expression/physiology | 2 | 0.0 |
Receptors, Chemokine/*genetics | 11 | 11.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Up-Regulation | 2 | 0.0 |
Adult | 14 | 0.0 |
Animals | 27 | 0.0 |
Cell Line | 12 | 0.0 |
Membrane Proteins/*physiology | 3 | 2.0 |
Protein Binding/immunology | 2 | 1.0 |
Rats | 8 | 0.0 |
Chromosomes, Human, Pair 3/*genetics | 2 | 0.0 |
Mice | 17 | 0.0 |
Blood Cells/metabolism | 2 | 6.0 |
Cell Movement | 6 | 0.0 |
Cells, Cultured | 13 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
Chemokines, CX3C/*metabolism | 2 | 66.0 |
*Cytotoxicity, Immunologic | 2 | 0.0 |
Membrane Proteins/*metabolism | 6 | 1.0 |
Receptors, Chemokine/*metabolism | 5 | 3.0 |
Killer Cells, Natural/*immunology | 3 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Comparative Study | 8 | 0.0 |
Male | 19 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Receptors, CCR5/metabolism | 2 | 1.0 |
Receptors, CXCR4/metabolism | 2 | 1.0 |
Receptors, Chemokine/metabolism | 3 | 2.0 |
Receptors, Cytokine/metabolism | 3 | 3.0 |
Cell Division/physiology | 2 | 0.0 |
Cell Adhesion/immunology | 2 | 1.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Solubility | 7 | 0.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Receptors, Cytokine/genetics | 5 | 15.0 |
Receptors, HIV/genetics | 5 | 50.0 |
Antigens, CD3/analysis | 2 | 0.0 |
Flow Cytometry | 10 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Exons | 2 | 0.0 |
Leukocytes, Mononuclear/metabolism | 5 | 2.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mutation | 5 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Transfection | 8 | 0.0 |
Alleles | 5 | 0.0 |
Cohort Studies | 6 | 0.0 |
Female | 18 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genotype | 4 | 0.0 |
Middle Aged | 11 | 0.0 |
Polymorphism, Genetic | 6 | 0.0 |
Risk Factors | 5 | 0.0 |
Enzyme Activation | 2 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Gene Expression/immunology | 2 | 2.0 |
Kinetics | 2 | 0.0 |
Rats, Inbred Lew | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Calcium/metabolism | 5 | 0.0 |
Inflammation/metabolism | 2 | 2.0 |
Intracellular Fluid/metabolism | 2 | 1.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Chemotaxis/drug effects | 3 | 3.0 |
Fibronectins/metabolism | 2 | 1.0 |
Intercellular Adhesion Molecule-1/metabolism | 2 | 1.0 |
Case-Control Studies | 3 | 0.0 |
Disease Progression | 6 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Chemotaxis, Leukocyte | 2 | 1.0 |
Interferon Type II/metabolism | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Chemotaxis/physiology | 2 | 6.0 |
Models, Molecular | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Receptors, Cytokine/*metabolism | 4 | 4.0 |
Receptors, HIV/*metabolism | 5 | 7.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Chemokines, CX3C | 10 | 83.0 |
Chemokines, CXC/*physiology | 2 | 5.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
France | 2 | 0.0 |
HIV/physiology | 2 | 5.0 |
Haplotypes | 3 | 0.0 |
Homozygote | 4 | 0.0 |
*Polymorphism, Single Nucleotide | 3 | 0.0 |
Monocytes/immunology | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Receptors, Chemokine/*analysis | 2 | 5.0 |
Chemokines/*pharmacology | 2 | 7.0 |
Receptors, Chemokine/*physiology | 2 | 4.0 |
Cell Adhesion | 4 | 0.0 |
Chemotaxis | 2 | 1.0 |
Membrane Proteins/metabolism | 4 | 0.0 |
Variation (Genetics) | 3 | 0.0 |
*Membrane Proteins | 6 | 0.0 |
*Receptors, G-Protein-Coupled | 2 | 0.0 |
Macrophages/metabolism | 2 | 0.0 |
Receptors, Chemokine/metabolism/*physiology | 2 | 22.0 |
Chemokines, CX3C/*biosynthesis/genetics | 2 | 66.0 |
Gene Expression | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Membrane Proteins/*biosynthesis/genetics | 2 | 5.0 |
Cloning, Molecular | 4 | 0.0 |
Chemokines/*metabolism | 2 | 3.0 |
GTP-Binding Proteins/metabolism | 3 | 1.0 |
*Signal Transduction | 2 | 0.0 |
Chemokines, CXC/*metabolism | 2 | 3.0 |
Receptors, Cytokine/genetics/*metabolism | 2 | 6.0 |
Receptors, HIV/genetics/*metabolism | 2 | 10.0 |
Ligands | 3 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
*HIV-1 | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Skin/immunology | 2 | 2.0 |
Cell Movement/*immunology | 2 | 2.0 |
Lymphocyte Subsets | 2 | 1.0 |
*Up-Regulation | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Arthritis, Rheumatoid/*metabolism | 2 | 3.0 |
Chemokines, CX3C/biosynthesis/*metabolism | 2 | 100.0 |
Membrane Proteins/biosynthesis/*metabolism | 2 | 15.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Phylogeny | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Cell Movement/*physiology | 3 | 1.0 |
Phenotype | 2 | 0.0 |
Receptors, Chemokine/genetics/metabolism | 2 | 8.0 |
Chemokines, CX3C/metabolism | 3 | 100.0 |
Viral Load | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
